Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer

NCT03193528 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.

NCT NCT03193528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03193528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer
Lead sponsor
Cedars-Sinai Medical Center
Phase
Observational
Overall status
Active, not recruiting
Start date
December 30, 2016
Completion date
July 31, 2026
Enrollment
450 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer